185 related articles for article (PubMed ID: 24715127)
1. A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience.
Abrol E; González-Pulido C; Praena-Fernández JM; Isenberg DA
Clin Med (Lond); 2014 Apr; 14(2):157-64. PubMed ID: 24715127
[TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
3. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
Ter Borg EJ; Kelder JC
Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
[TBL] [Abstract][Full Text] [Related]
4. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
5. Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS.
Zufferey P; Meyer OC; Grossin M; Kahn MF
Scand J Rheumatol; 1995; 24(6):342-5. PubMed ID: 8610217
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of clinical features and prognosis in patients with primary Sjögren's syndrome and autoimmune liver disease].
Chen WQ; Dai XN; Yu Y; Wang Q; Liang JY; Ke YN; Yi CH; Lin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):886-891. PubMed ID: 33047724
[TBL] [Abstract][Full Text] [Related]
7. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
8. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
Le Guern V; Mouthon L
Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
[TBL] [Abstract][Full Text] [Related]
9. Extraglandular ocular involvement and morbidity and mortality in primary Sjögren's Syndrome.
Mathews PM; Robinson SA; Gire A; Baer AN; Akpek EK
PLoS One; 2020; 15(9):e0239769. PubMed ID: 32976549
[TBL] [Abstract][Full Text] [Related]
10. Mortality in Sjögren's syndrome.
Voulgarelis M; Tzioufas AG; Moutsopoulos HM
Clin Exp Rheumatol; 2008; 26(5 Suppl 51):S66-71. PubMed ID: 19026146
[TBL] [Abstract][Full Text] [Related]
11. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
[TBL] [Abstract][Full Text] [Related]
12. The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren's syndrome: a single-centre, retrospective cohort study.
Mayer M; Martinic M; Reihl-Crnogaj M; Anic B
Rheumatol Int; 2023 Nov; 43(11):2031-2036. PubMed ID: 37491526
[TBL] [Abstract][Full Text] [Related]
13. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract][Full Text] [Related]
14. Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjögren's syndrome measured using the Korean Health Insurance Claims Database.
Ahn JK; Hwang J; Seo GH
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):40-46. PubMed ID: 31969226
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
16. Thyroid disease in Sjögren's syndrome.
Jara LJ; Navarro C; Brito-Zerón Mdel P; García-Carrasco M; Escárcega RO; Ramos-Casals M
Clin Rheumatol; 2007 Oct; 26(10):1601-6. PubMed ID: 17558463
[TBL] [Abstract][Full Text] [Related]
17. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
18. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.
Davidson BK; Kelly CA; Griffiths ID
Rheumatology (Oxford); 1999 Mar; 38(3):245-53. PubMed ID: 10325663
[TBL] [Abstract][Full Text] [Related]
19. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
Liang Y; Yang Z; Qin B; Zhong R
Ann Rheum Dis; 2014 Jun; 73(6):1151-6. PubMed ID: 23687261
[TBL] [Abstract][Full Text] [Related]
20. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
